Atypical Spitzoid melanocytic tumors: A morphological, mutational, and FISH analysis - 10/08/11
Abstract |
Background |
Identification of the clinical behavior of atypical Spitzoid tumors with conflicting histopathologic features remains controversial.
Objective |
We sought to assess whether molecular findings may be helpful in the diagnostic and prognostic assessment of atypical Spitzoid tumors.
Methods |
A total of 38 controversial, atypical Spitzoid lesions (≥1 mm in thickness) were analyzed for clinicopathological features, chromosomal alterations by fluorescence in situ hybridization (FISH) analysis (RREB1/MYB/CCND1/CEP6), BRAFV600E mutation by allele-specific real-time polymerase chain reaction confirmed by sequencing, and H-RAS gene mutation by direct sequencing.
Results |
Atypical Spitzoid lesions developed in 21 female and 17 male patients (mean age 22 years). Nine patients underwent sentinel lymph node biopsy and a sentinel lymph node micrometastasis was detected in 4 of these 9 cases. Four additional patients, who did not receive a sentinel lymph node biopsy, experienced bulky lymph node metastases and one experienced visceral metastases and death. Lesions from patients with lymph node involvement showed more deep mitoses (P < .01), less inflammation (P = .05), and more plasma cells (P = .04). FISH analysis demonstrated the presence of chromosomal alterations in 6 of 25 cases. Correlation with follow-up data showed that the only case with fatal outcome showed multiple chromosomal alterations by FISH analysis. BRAFV600E mutation was detected in 12 of 16 cases (75%) and H-RAS mutation on exon 3 was found in 3 of 11 cases (27%).
Limitations |
Our results require validation in a larger series with longer follow-up information.
Conclusions |
FISH assay may be of help in the prognostic evaluation of atypical Spitzoid tumors. Diagnostic significance of BRAFV600E and H-RAS mutations in this setting remains unclear.
Le texte complet de cet article est disponible en PDF.Key words : atypical Spitz nevus, atypical Spitzoid tumor, BRAFV600E, fluorescence in situ hybridization, H-RAS, mutation, sentinel lymph node, Spitzoid melanoma
Plan
The first two authors contributed equally to this work. |
|
Dr Lukic was a visiting fellow at CRO-Istituto Nazionale Tumori, Aviano. |
|
Supported in part by Abbott Molecular Inc by the research project “Integrazione delle attività di ricerca attraverso la costruzione di strutture e reti di collaborazione interistituzionali–Rete Nazionale Telepatologia (TESEO)” ACC/R8.5; by the research project “Oncoproteomica” Convenzione n. 527/B/3A/3, ISS, Roma (Dr Canzonieri); and by Fondazione Ente Cassa di Risparmio di Firenze (Dr Massi). |
|
Conflicts of interest: None declared. |
Vol 64 - N° 5
P. 919-935 - mai 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?